13F filer · CIK 1697748 ↗
ARK Invest
You are looking at Q4 2024. See the latest, Q2 2026 →
Reported value
$12.01B
+9.8% on the quarter before
Positions
183
7 new · 18 sold out
Top 10
50.6%
of the value
Est. gain
+$1.68B
on stocks held all quarter
Est. return
+17.7%
on those stocks since Q3 2024
Positions as of Dec 31, 2024, from ARK Invest's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2024. Striped tiles are options.
Largest buys
Since Q3 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Amazon~$119.8MAdded · 0.6% → 1.6%+546,252 shares
- Tempus AI~$106.1MAdded · 1.2% → 1.6%+3,141,487 shares
- Illumina Inc~$91.7MNew · 0.0% → 0.8%+686,330 shares
- Archer Aviation Inc~$62.1MAdded · 0.7% → 2.4%+6,371,647 shares
- Crispr Therapeutics Ag~$58.0MAdded · 3.2% → 2.9%+1,474,439 shares
- AMD~$50.9MAdded · 1.2% → 1.2%+421,275 shares
- Gitlab Inc~$50.7MAdded · 0.1% → 0.5%+899,823 shares
- Teradyne~$49.2MAdded · 1.9% → 2.0%+390,397 shares
- Meta~$38.9MAdded · 2.1% → 2.3%+66,473 shares
- Natera Inc~$31.7MAdded · 0.8% → 1.2%+200,008 shares
Largest sells
Since Q3 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Tesla~$525.6MCut · 11.0% → 11.1%−1,301,429 shares
- Palantir~$243.9MCut · 3.7% → 4.9%−3,224,331 shares
- Robinhood~$188.8MCut · 3.8% → 4.0%−5,067,173 shares
- Block~$144.3MCut · 4.1% → 3.5%−1,697,551 shares
- Unity Software Inc~$124.4MCut · 1.4% → 0.2%−5,535,965 shares
- Roblox~$98.3MCut · 4.8% → 4.9%−1,698,859 shares
- Moderna Inc~$77.8MSold out · 0.7% → 0.0%−1,163,946 shares
- Rocket Lab Usa Inc~$52.6MCut · 0.5% → 0.7%−2,064,445 shares
- Coinbase~$51.3MCut · 5.3% → 6.3%−206,553 shares
- Sofi Technologies Inc~$49.6MCut · 0.9% → 1.2%−3,221,361 shares
Holdings
As of Dec 31, 2024. Changes are in shares against Sep 30, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TeslaCommon Stock · shares −28% · price +54.4% | 11.1% | $1.33B | +$467.5M | ||||||||
| Roku IncCommon Stock · shares −4.9% · price −0.4% | 6.6% | $793.4M | −$3.4M | ||||||||
| CoinbaseCommon Stock · shares −6.4% · price +39.4% | 6.3% | $753.5M | +$212.8M | ||||||||
| PalantirCommon Stock · shares −29% · price +103.3% | 4.9% | $589.4M | +$299.5M | ||||||||
| RobloxCommon Stock · shares −14% · price +30.7% | 4.9% | $586.8M | +$137.9M | ||||||||
| RobinhoodCommon Stock · shares −28% · price +59.1% | 4.0% | $480.9M | +$178.6M | ||||||||
| Shopify IncCommon Stock · shares −3.6% · price +32.7% | 4.0% | $479.0M | +$118.0M | ||||||||
| BlockCommon Stock · shares −26% · price +26.6% | 3.5% | $418.8M | +$88.0M | ||||||||
| Crispr Therapeutics AgCommon Stock · shares +20% · price −16.2% | 2.9% | $353.2M | −$57.1M | ||||||||
| Archer Aviation IncCommon Stock · shares +27% · price +221.8% | 2.4% | $291.6M | +$158.2M | ||||||||
| Ark 21shares Bitcoin ETFETP · shares −1.4% · price +47.0% | 2.4% | $289.2M | +$92.4M | ||||||||
| MetaCommon Stock · shares +17% · price +2.3% | 2.3% | $271.9M | +$5.2M | ||||||||
| Twist Bioscience CorpCommon Stock · shares +4.4% · price +2.9% | 2.2% | $260.0M | +$6.9M | ||||||||
| UiPathCommon Stock · shares −6.4% · price −0.7% | 2.1% | $249.2M | −$1.8M | ||||||||
| TeradyneCommon Stock · shares +25% · price −6.0% | 2.0% | $242.1M | −$12.3M | ||||||||
| Recursion Pharmaceuticals IncCommon Stock · shares −1.3% · price +2.6% | 1.8% | $218.7M | +$5.5M | ||||||||
| Draftkings IncCommon Stock · shares −8.1% · price −5.1% | 1.7% | $205.9M | −$11.1M | ||||||||
| AmazonCommon Stock · shares +157% · price +17.7% | 1.6% | $196.4M | +$11.5M | ||||||||
| Tempus AICommon Stock · shares +132% · price −40.4% | 1.6% | $186.3M | −$54.3M | ||||||||
| Beam Therapeutics IncCommon Stock · shares +8.2% · price +1.2% | 1.5% | $175.3M | +$2.0M | ||||||||
| 10x Genomics IncCommon Stock · shares +11% · price −36.4% | 1.4% | $171.5M | −$88.4M | ||||||||
| Veracyte IncCommon Stock · shares −15% · price +16.3% | 1.4% | $166.5M | +$23.4M | ||||||||
| Pagerduty IncCommon Stock · shares −7.7% · price −1.6% | 1.4% | $164.3M | −$2.6M | ||||||||
| The Trade DeskCommon Stock · shares +0.4% · price +7.2% | 1.2% | $149.4M | +$10.0M | ||||||||
| Intellia Therapeutics IncCommon Stock · shares +2.3% · price −43.3% | 1.2% | $146.2M | −$109.0M | ||||||||
| Total · 183 positions | 100% | $12.01B | +$1.68B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2024 to Q4 2024: 175 stocks held throughout, up $1.68B (+17.7%).
- Tesla+$467.5M+54%
- Palantir+$299.5M+103%
- Coinbase+$212.8M+39%
- Robinhood+$178.6M+59%
- Archer Aviation Inc+$158.2M+222%
- AMD−$34.0M−26%
- Tempus AI−$54.3M−40%
- Crispr Therapeutics Ag−$57.1M−16%
- 10x Genomics Inc−$88.4M−36%
- Intellia Therapeutics Inc−$109.0M−43%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $15.40B+20% | SEC ↗ |
| Q1 2026 | May 12, 2026 | $12.86B−15% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $15.07B−10% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $16.80B+23% | SEC ↗ |
| Q2 2025 | Jul 30, 2025 | $13.64B+37% | SEC ↗ |
| Q1 2025 | May 7, 2025 | $9.99B−17% | SEC ↗ |
| Q4 2024 | Feb 4, 2025 | $12.01B+10% | SEC ↗ |
| Q3 2024 | Oct 31, 2024 | $10.93B−3% | SEC ↗ |
| Q2 2024 | Jul 26, 2024 | $11.27B−22% | SEC ↗ |
| Q1 2024 | Apr 18, 2024 | $14.44B−14% | SEC ↗ |
| Q4 2023 | Jan 17, 2024 | $16.89B+29% | SEC ↗ |
| Q3 2023 | Oct 18, 2023 | $13.07B−13% | SEC ↗ |
| Q2 2023 | Jul 10, 2023 | $15.10B+4% | SEC ↗ |
| Q1 2023 | Apr 17, 2023 | $14.55B+26% | SEC ↗ |
| Q4 2022 | Jan 24, 2023 | $11.54B−20% | SEC ↗ |
| Q3 2022 | Oct 17, 2022 | $14.35B−15% | SEC ↗ |
| Q2 2022 | Jul 11, 2022 | $16.91B−29% | SEC ↗ |
| Q1 2022 | Apr 18, 2022 | $23.96B−28% | SEC ↗ |
| Q4 2021 | Jan 28, 2022 | $33.08B−21% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $41.64B−23% | SEC ↗ |
| Q2 2021 | Aug 5, 2021 | $53.74B+7% | SEC ↗ |
| Q1 2021 | May 13, 2021 | $50.34B+34% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $37.59B+123% | SEC ↗ |
| Q3 2020 | Oct 30, 2020 | $16.86B+81% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $9.30B+132% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $4.01B+1% | SEC ↗ |
| Q4 2019 | Jan 31, 2020 | $3.96B−13% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $4.58B+15% | SEC ↗ |
| Q2 2019 | Jul 30, 2019 | $3.97B+13% | SEC ↗ |
| Q1 2019 | May 13, 2019 | $3.50B+42% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 (amended) | $2.46B−26% | SEC ↗ |
| Q3 2018 | Nov 7, 2018 | $3.31B+21% | SEC ↗ |
| Q2 2018 | Aug 7, 2018 | $2.73B+36% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $2.01B+60% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $1.26B+53% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $819.3M+60% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $513.6M+48% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $346.9M+26% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 | $274.9M | SEC ↗ |